메뉴 건너뛰기




Volumn 117, Issue 4, 2016, Pages 647-655

Statin Use and the Risk of Kidney Disease with Long-Term Follow-Up (8.4-Year Study)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PRAVASTATIN; SIMVASTATIN;

EID: 84958922667     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2015.11.031     Document Type: Article
Times cited : (33)

References (30)
  • 2
    • 77953711938 scopus 로고    scopus 로고
    • Unintended effects of statins in men and women in England and Wales: Population based cohort study using the QResearch database
    • J. Hippisley-Cox, and C. Coupland Unintended effects of statins in men and women in England and Wales: population based cohort study using the QResearch database BMJ 340 2010 c2197
    • (2010) BMJ , vol.340 , pp. c2197
    • Hippisley-Cox, J.1    Coupland, C.2
  • 3
    • 84875420550 scopus 로고    scopus 로고
    • Use of high potency statins and rates of admission for acute kidney injury: Multicenter, retrospective observational analysis of administrative databases
    • C.R. Dormuth, B.R. Hemmelgarn, J.M. Paterson, M.T. James, G.F. Teare, C.B. Raymond, J.P. Lafrance, A. Levy, A.X. Garg, P. Ernst Canadian Network for Observational Drug Effect Studies Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases BMJ 346 2013 f880
    • (2013) BMJ , vol.346 , pp. f880
    • Dormuth, C.R.1    Hemmelgarn, B.R.2    Paterson, J.M.3    James, M.T.4    Teare, G.F.5    Raymond, C.B.6    Lafrance, J.P.7    Levy, A.8    Garg, A.X.9    Ernst, P.10
  • 4
    • 84901618597 scopus 로고    scopus 로고
    • Statin and the risk of renal-related serious adverse events: Analysis from the IDEAL, TNT, CARDS, ASPEN, SPARCL, and other placebo-controlled trials
    • S. Bangalore, R. Fayyad, G.K. Hovingh, R. Laskey, L. Vogt, D.A. DeMicco, D.D. Waters Treating to New Targets Steering Committee and Investigators Statin and the risk of renal-related serious adverse events: analysis from the IDEAL, TNT, CARDS, ASPEN, SPARCL, and other placebo-controlled trials Am J Cardiol 113 2014 2018 2020
    • (2014) Am J Cardiol , vol.113 , pp. 2018-2020
    • Bangalore, S.1    Fayyad, R.2    Hovingh, G.K.3    Laskey, R.4    Vogt, L.5    DeMicco, D.A.6    Waters, D.D.7
  • 5
    • 84923378330 scopus 로고    scopus 로고
    • The incidence of kidney injury for patients treated with a high-potency versus moderate-potency statin regimen after an acute coronary syndrome
    • A. Sarma, C.P. Cannon, J. de Lemos, J.L. Rouleau, E.F. Lewis, J. Guo, J.L. Mega, M.S. Sabatine, and M.L. O'Donoghue The incidence of kidney injury for patients treated with a high-potency versus moderate-potency statin regimen after an acute coronary syndrome J Am Heart Assoc 3 2014 e000784
    • (2014) J Am Heart Assoc , vol.3 , pp. e000784
    • Sarma, A.1    Cannon, C.P.2    De Lemos, J.3    Rouleau, J.L.4    Lewis, E.F.5    Guo, J.6    Mega, J.L.7    Sabatine, M.S.8    O'Donoghue, M.L.9
  • 7
    • 84942789057 scopus 로고    scopus 로고
    • Statin adverse events in primary prevention: Between randomized trials and observational studies
    • I. Mansi Statin adverse events in primary prevention: between randomized trials and observational studies Am J Med Sci 350 2015 330 337
    • (2015) Am J Med Sci , vol.350 , pp. 330-337
    • Mansi, I.1
  • 8
    • 84876553028 scopus 로고    scopus 로고
    • The controversy of a wider statin utilization: Why?
    • I. Mansi, and E. Mortensen The controversy of a wider statin utilization: why? Expert Opin Drug Saf 12 2013 327 337
    • (2013) Expert Opin Drug Saf , vol.12 , pp. 327-337
    • Mansi, I.1    Mortensen, E.2
  • 9
    • 84928584490 scopus 로고    scopus 로고
    • Comparison of frequency of inflammatory bowel disease and noninfectious gastroenteritis among statin users versus nonusers
    • D. Khalil, M. Boktor, E.M. Mortensen, C.R. Frei, and I. Mansi Comparison of frequency of inflammatory bowel disease and noninfectious gastroenteritis among statin users versus nonusers Am J Cardiol 115 2015 1396 1401
    • (2015) Am J Cardiol , vol.115 , pp. 1396-1401
    • Khalil, D.1    Boktor, M.2    Mortensen, E.M.3    Frei, C.R.4    Mansi, I.5
  • 10
    • 84945470638 scopus 로고    scopus 로고
    • Statins and new-onset diabetes mellitus and diabetic complications: A retrospective cohort study of US healthy adults
    • I. Mansi, C.R. Frei, C.P. Wang, and E.M. Mortensen Statins and new-onset diabetes mellitus and diabetic complications: a retrospective cohort study of US healthy adults J Gen Intern Med 30 2015 1599 1610
    • (2015) J Gen Intern Med , vol.30 , pp. 1599-1610
    • Mansi, I.1    Frei, C.R.2    Wang, C.P.3    Mortensen, E.M.4
  • 12
    • 84958867600 scopus 로고    scopus 로고
    • Office of the Assistant Secretary of Defense for Health Affairs (OSAD-HA) TRICARE Management Activity (TMA) Human Research Protection Program (HRPP) Available at: Accessed on March 16, 2015
    • Guide for DoD Researchers on Using MHS Data 2012 Office of the Assistant Secretary of Defense for Health Affairs (OSAD-HA) TRICARE Management Activity (TMA) Human Research Protection Program (HRPP) Available at: http://health.mil/Reference-Center/Publications/2012/10/10/Guide-for-DoD-Researchers-on-Using-MHS-Data Accessed on March 16, 2015
    • (2012) Guide for DoD Researchers on Using MHS Data
  • 13
    • 33947374141 scopus 로고    scopus 로고
    • U.S. Agency for Healthcare Research and Quality Available at: Accessed on March 16, 2015
    • Clinical Classifications Software (CCS) for ICD-9-cm 2012 U.S. Agency for Healthcare Research and Quality Available at: http://www.hcup-us.ahrq.gov/toolssoftware/ccs/ccs.jsp Accessed on March 16, 2015
    • (2012) Clinical Classifications Software (CCS) for ICD-9-cm
  • 16
    • 84876692093 scopus 로고    scopus 로고
    • Comparative analysis of pharmacovigilance methods in the detection of adverse drug reactions using electronic medical records
    • M. Liu, E.R. McPeek Hinz, M.E. Matheny, J.C. Denny, J.S. Schildcrout, R.A. Miller, and H. Xu Comparative analysis of pharmacovigilance methods in the detection of adverse drug reactions using electronic medical records J Am Med Inform Assoc 20 2013 420 426
    • (2013) J Am Med Inform Assoc , vol.20 , pp. 420-426
    • Liu, M.1    McPeek Hinz, E.R.2    Matheny, M.E.3    Denny, J.C.4    Schildcrout, J.S.5    Miller, R.A.6    Xu, H.7
  • 17
    • 41149096954 scopus 로고    scopus 로고
    • Regression tree boosting to adjust health care cost predictions for diagnostic mix
    • J.W. Robinson Regression tree boosting to adjust health care cost predictions for diagnostic mix Health Serv Res 43 2008 755 772
    • (2008) Health Serv Res , vol.43 , pp. 755-772
    • Robinson, J.W.1
  • 18
    • 0026639706 scopus 로고
    • Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases
    • R.A. Deyo, D.C. Cherkin, and M.A. Ciol Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases J Clin Epidemiol 45 1992 613 619
    • (1992) J Clin Epidemiol , vol.45 , pp. 613-619
    • Deyo, R.A.1    Cherkin, D.C.2    Ciol, M.A.3
  • 20
    • 0036242532 scopus 로고    scopus 로고
    • Calculating the "number needed to be exposed" with adjustment for confounding variables in epidemiological studies
    • R. Bender, and M. Blettner Calculating the "number needed to be exposed" with adjustment for confounding variables in epidemiological studies J Clin Epidemiol 55 2002 525 530
    • (2002) J Clin Epidemiol , vol.55 , pp. 525-530
    • Bender, R.1    Blettner, M.2
  • 23
    • 3042604519 scopus 로고    scopus 로고
    • Dangers of rosuvastatin identified before and after FDA approval
    • S.M. Wolfe Dangers of rosuvastatin identified before and after FDA approval Lancet 363 2004 2189 2190
    • (2004) Lancet , vol.363 , pp. 2189-2190
    • Wolfe, S.M.1
  • 24
    • 70350121639 scopus 로고    scopus 로고
    • Effects of atorvastatin on kidney outcomes and cardiovascular disease in patients with diabetes: An analysis from the Collaborative Atorvastatin Diabetes Study (CARDS)
    • H.M. Colhoun, D.J. Betteridge, P.N. Durrington, G.A. Hitman, H.A. Neil, S.J. Livingstone, V. Charlton-Menys, D.A. DeMicco, J.H. Fuller CARDS Investigators Effects of atorvastatin on kidney outcomes and cardiovascular disease in patients with diabetes: an analysis from the Collaborative Atorvastatin Diabetes Study (CARDS) Am J Kidney Dis 54 2009 810 819
    • (2009) Am J Kidney Dis , vol.54 , pp. 810-819
    • Colhoun, H.M.1    Betteridge, D.J.2    Durrington, P.N.3    Hitman, G.A.4    Neil, H.A.5    Livingstone, S.J.6    Charlton-Menys, V.7    DeMicco, D.A.8    Fuller, J.H.9
  • 25
    • 77949332406 scopus 로고    scopus 로고
    • Efficacy of rosuvastatin among men and women with moderate chronic kidney disease and elevated high-sensitivity C-reactive protein: A secondary analysis from the JUPITER (Justification for the Use of Statins in Prevention - An Intervention Trial Evaluating Rosuvastatin) trial
    • P.M. Ridker, J. MacFadyen, M. Cressman, and R.J. Glynn Efficacy of rosuvastatin among men and women with moderate chronic kidney disease and elevated high-sensitivity C-reactive protein: a secondary analysis from the JUPITER (Justification for the Use of Statins in Prevention - an Intervention Trial Evaluating Rosuvastatin) trial J Am Coll Cardiol 55 2010 1266 1273
    • (2010) J Am Coll Cardiol , vol.55 , pp. 1266-1273
    • Ridker, P.M.1    MacFadyen, J.2    Cressman, M.3    Glynn, R.J.4
  • 26
    • 64749101006 scopus 로고    scopus 로고
    • Focused atorvastatin therapy in managed-care patients with coronary heart disease and CKD
    • M.J. Koren, M.H. Davidson, D.J. Wilson, R.S. Fayyad, A. Zuckerman, D.P. Reed ALLIANCE Investigators Focused atorvastatin therapy in managed-care patients with coronary heart disease and CKD Am J Kidney Dis 53 2009 741 750
    • (2009) Am J Kidney Dis , vol.53 , pp. 741-750
    • Koren, M.J.1    Davidson, M.H.2    Wilson, D.J.3    Fayyad, R.S.4    Zuckerman, A.5    Reed, D.P.6
  • 27
    • 1542298565 scopus 로고    scopus 로고
    • The effect of statins versus untreated dyslipidaemia on renal function in patients with coronary heart disease. A subgroup analysis of the Greek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) study
    • V.G. Athyros, D.P. Mikhailidis, A.A. Papageorgiou, A.N. Symeonidis, A.N. Pehlivanidis, V.I. Bouloukos, and M. Elisaf The effect of statins versus untreated dyslipidaemia on renal function in patients with coronary heart disease. A subgroup analysis of the Greek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) study J Clin Pathol 57 2004 728 734
    • (2004) J Clin Pathol , vol.57 , pp. 728-734
    • Athyros, V.G.1    Mikhailidis, D.P.2    Papageorgiou, A.A.3    Symeonidis, A.N.4    Pehlivanidis, A.N.5    Bouloukos, V.I.6    Elisaf, M.7
  • 28
    • 38449119409 scopus 로고    scopus 로고
    • Effect of intensive lipid lowering with atorvastatin on renal function in patients with coronary heart disease: The Treating to New Targets (TNT) study
    • J. Shepherd, J.J. Kastelein, V. Bittner, P. Deedwania, A. Breazna, S. Dobson, D.J. Wilson, A. Zuckerman, N.K. Wenger Treating to New Targets Investigators Effect of intensive lipid lowering with atorvastatin on renal function in patients with coronary heart disease: the Treating to New Targets (TNT) study Clin J Am Soc Nephrol 2 2007 1131 1139
    • (2007) Clin J Am Soc Nephrol , vol.2 , pp. 1131-1139
    • Shepherd, J.1    Kastelein, J.J.2    Bittner, V.3    Deedwania, P.4    Breazna, A.5    Dobson, S.6    Wilson, D.J.7    Zuckerman, A.8    Wenger, N.K.9
  • 30
    • 84939973885 scopus 로고    scopus 로고
    • Should we use statins in all patients with chronic kidney disease without dialysis therapy? the current state of knowledge
    • J. Rysz, A. Gluba-Brzozka, M. Banach, and A. Wiecek Should we use statins in all patients with chronic kidney disease without dialysis therapy? The current state of knowledge Int Urol Nephrol 47 2015 805 813
    • (2015) Int Urol Nephrol , vol.47 , pp. 805-813
    • Rysz, J.1    Gluba-Brzozka, A.2    Banach, M.3    Wiecek, A.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.